Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years

被引：0
|
作者：
Arzu Soybilgic
Karen B Onel
Tammy Utset
Kenneth Alexander
Linda Wagner-Weiner
机构：
[1] University of Illinois,
[2] University of Chicago,undefined
来源：
Pediatric Rheumatology | / 11卷
关键词：
Human papillomavirus; Lupus; Safety; Immunogenicity; Pediatric; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus (SLE).
    Kuruma, Katia A. M.
    Borba, Eduardo F.
    Lopes, Marta Eloisa
    Carvalho, Jozelio F.
    Bonfa, Eloisa
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S275 - S275
  • [42] USE OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE RELATIONSHIP OF IMMUNOGENICITY WITH THERAPY
    Tarasova, Galina
    Belov, Boris
    Bukhanova, Daria
    Cherkasova, Maria
    Solovyev, Sergey
    Aseeva, Elena
    Reshetnyak, Tatiana
    Popkova, Tatiana
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 785 - 786
  • [43] INFLUENCE OF VARIOUS FACTORS ON THE IMMUNOGENICITY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 614 - 615
  • [44] COMORBIDITIES AND SAFETY EVENTS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Krueger, W.
    Feger, D.
    Friedman, A.
    Doan, T.
    D'silva, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1106 - 1106
  • [45] EFFICACY AND SAFETY OF RITUXIMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Ren, Y.
    Wang, L.
    An, Z.
    Yang, L.
    Su, Q. Y.
    Yu, Q.
    He, P. F.
    Li, X.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1477 - 1477
  • [46] Characteristics and safety of tattoos in patients with systemic lupus erythematosus
    Sabio, J. M.
    De Betolaza, S.
    Vargas-Hitos, J. A.
    LUPUS, 2019, 28 (10) : 1250 - 1254
  • [47] Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa
    Mugo, Nelly
    Ansah, Nana Akosua
    Marino, Deborah
    Saah, Alfred
    Garner, Elizabeth I. O.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (06) : 1323 - 1330
  • [48] A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients
    Chanprapaph, K.
    Sawatwarakul, S.
    Vachiramon, V.
    LUPUS, 2017, 26 (12) : 1278 - 1284
  • [49] A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients
    Pons-Estel, G. J.
    Quintana, R.
    Alarcon, G. S.
    Sacnun, M.
    Ugarte-Gil, M. F.
    Pons-Estel, B. A.
    LUPUS, 2018, 27 (10) : 1753 - 1754
  • [50] Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis
    Liao, Zhengfa
    Tang, Hao
    Xu, Xiaojia
    Liang, Yaping
    Xiong, Yongzhen
    Ni, Jindong
    PLOS ONE, 2016, 11 (02):
12345